Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos

NeuroToxicology

Volumn 27, Issue 4, 2006, Pages 547-557

  Wlodarczyk, Bogdan J ^a   Cabrera, Robert M ^a   Hill, Denise S ^a   Bozinov, Daniel ^a   Zhu, Huiping ^a   Finnell, Richard H ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Folr2 knockout mouse; Microarray; Neural tube; Sodium arsenate

Indexed keywords

ARSENATE SODIUM; ARSENIC; EPHRIN; FOLIC ACID; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; EMBRYO; EXENCEPHALY; EXPOSURE; GENE EXPRESSION; INCIDENCE; MEDICAL TECHNOLOGY; MORPHOGENESIS; MOUSE; NEURAL TUBE; NEURAL TUBE DEFECT; NONHUMAN; ORGANOGENESIS; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; AGE FACTORS; ANIMALS; ARSENIC; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; EMBRYO; EPHRINS; FEMALE; FOLIC ACID; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; NEURAL TUBE DEFECTS; PLATELET-DERIVED GROWTH FACTOR; PREGNANCY; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

CRICETINAE; MURINAE; RODENTIA;

EID: 33744972609     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2006.02.005     Document Type: Article

References (77)

1. Agency for Toxic Substances and Disease Registry. CERCLA Priority List of Hazardous Substances; 2005. http://www.atsdr.cdc.gov/clist.html.
2. Akay C., Thomas C., and Gazitt Y. Arsenic trioxide and paclitaxel induce apoptosis by different mechanisms. Cell Cycle 3 3 (2004) 324-334
3. Aposhian H.V., Zakharyan R.A., Avram M.D., Kopplin M.J., and Wollenberg M.L. Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharmacol 193 (2003) 1-8
4. Aposhian V.H., Zakharyan R.A., Avram M.D., Sampayo-Reyes A., and Wollenberg M.L. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol Appl Pharmacol 198 (2004) 327-335
5. Armstrong C.W., Stroube R.B., Rubio T., Siudyla E.A., and Miller G.B. Outbreak of fatal arsenic poisoning caused by contaminated drinking water. Arch Environ Health 39 (1984) 276-279
6. Aschengrau A., Zierler S., and Cohen A. Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health 44 (1989) 283-290
7. Augustine K.A., Liu E.T., and Sadler T.W. Antisense inhibition of engrailed genes in mouse embryos reveals roles for these genes in craniofacial and neural tube development. Teratology 51 5 (1995) 300-310
8. Barber R.C., Bennett G.D., Greer K.A., and Finnell R.H. Expression patterns of folate binding proteins one and two in the developing mouse embryo. Mol Genet Metab 66 (1999) 31-39
9. Baxley M.N., Hood R.D., Vedel G.C., Harrison W.P., and Szczech G.M. Prenatal toxicity of orally administered sodium arsenite in mice. Bull Environ Contam Toxicol 26 (1981) 749-756
10. Beckman L., and Nordstrom S. Ocupational and environmental risks in and around a smelter in northern Sweden. IX. Fetal mortalities among wives of smelter workers. Hereditas 97 (1982) 1-7
11. Bolliger C.T., van Zijl P., and Louw J.A. Multiple organ failure with the adult respiratory distress syndrome in homicidal arsenic poisoning. Respiration 59 (1992) 57-61
12. Borzsonyi M., Bereczky A., Rudna P., Csanady M., and Horvath A. Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Arch Toxicol 66 (1992) 77-78
13. Brown J.G., and Ross G.L. Arsenic, drinking water, and health: a position paper of the American Council on science and health. Regul Toxicol Pharmacol 36 (2002) 162-174
14. Carter D.E., Aposhian H.V., and Gandolfi A.J. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol Appl Pharmacol 193 (2003) 309-334
15. Chacko G., Ling Q., and Hajjar K. Induction of acute translational response genes by homocysteine. J Biol Chem 273 31 (1998) 19840-19846
16. Chaineau E., Binet S., Pol D., Chatellier G., and Meininger V. Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture. Teratology 41 (1990) 105-112
17. Chan W., Ng T., Wu P., and Yeung H. Developmental toxicity and teratogenicity of trichosanthin, a ribosome-inactivating protein, in mice. Teratog Carcinog Mutagen 13 2 (1993) 47-57
18. Chan W., Ng T., and Yeung H. Differential abilities of the ribosome inactivating proteins luffaculin, luffins and momorcochin to induce abnormalities in developing mouse embryos in vitro. Gen Pharmacol 25 2 (1994) 363-367
19. Concha G., Vogler G., Lezcano D., Nermell B., and Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44 (1998) 185-190
20. Condeelis J. Elongation factor 1α, translation and the cytoskeleton. Trends Biochem Sci 20 5 (1995) 169-170
21. Conway K., McConnell B., Bowring C., Donald C., Warren S., and Vertino P. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 60 22 (2000) 6236-6242
22. Depaepe V., Suarez-Gonzalez N., Dufour A., Passante L., Gorski J., Jones K., et al. Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. Nature 435 7046 (2005) 1244-1250
23. DeSesso J.M. Teratogen update: inorganic arsenic. Teratology 63 (2001) 170-173
24. DeSesso J.M., Jacobson C.F., Scialli A.R., Farr C.H., and Holson J.F. An assessment of the developmental toxicity of inorganic arsenic. Reprod Toxicol 12 (1998) 389-433
25. Eastman N.J., and Dippel A.L. The passage of arsenic through the human placenta following arsphenamine therapy. Bull Johns Hopkins Hospital 53 (1933) 288-297
26. Eberwine J., Yeh H., Miyashiro K., Cao Y., Nair S., Finnell R., et al. Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 89 (1992) 3010-3014
27. Ferm V.H. Arsenic as a teratogenic agent. Environ Health Perspect 19 (1977) 215-217
28. Golub M.S., Macintosh M.S., and Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J Toxicol Environ Health B Crit Rev 1 (1998) 199-241
29. Hershey J.W. Translational control in mammalian cells. Annu Rev Biochem 60 (1991) 717-755
30. Holson J.F., DeSesso J.M., Jacobson C.F., and Farr H.F. Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic. Teratology 62 (2000) 51-71
31. Hood R.D., and Harrison W.P. Effects of prenatal arsenite exposure in the hamster. Bull Environ Contam Toxicol 29 (1982) 671-678
32. Hood R.D., Thacker G.T., Patterson B.L., and Szczech G.M. Prenatal effects of oral versus intraperitoneal sodium arsenate in mice. J Environ Pathol Toxicol 1 (1978) 857-864
33. Hunter E.S., and Dix D. Heat shock proteins Hsp70-1 and Hsp70-3 Are necessary and sufficient to prevent arsenite-induced dysmorphology in mouse embryos. Mol Reprod Dev 59 (2001) 285-293
34. ICPS, International Programme on Chemical Safety. World Health Organization Report, Environmental Health Criteria Monographs (18), Arsenic; 1981. http://www.inchem.org/documents/jecfa/jecmono/v18je17.htm.
35. ICPS, International Programme on Chemical Safety. World Health Organization Report, Inorganic arsenic compounds other than arsine, health and safety guide No 70; 1992 http://www.inchem.org/documents/hsg/hsg/hsg070.htm.
36. ICPS, International Programme on Chemical Safety. World Health Organization Report, Environmental Health Criteria Monographs (224), Arsenic and arsenic compounds; 2001 http://www.inchem.org/documents/ehc/ehc/ehc224.htm.
37. Ihrig M.M., Shalat S.L., and Baynes C. A hospital-based case-control study of stillbirth and environmental exposure to arsenic using an atmospheric dispersion model linked to a geographical information system. Epidemiology 9 (1998) 290-294
38. Le X.C., Ma M., Cullen W.R., Aposhian H.V., Lu X., and Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 108 (2000) 1015-1018
39. Liu J., Kadiiska M., Liu Y., Lu T., Qu W., and Waalkes M. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci. 61 2 (2001) 314-320
40. Liu Q., Kishi H., Ohtsuka K., and Muraguchi A. Heat shock protein 70 binds caspase-activated DNase and enhances its activity in TCR-stimulated T cells. Blood 102 5 (2003) 1788-1796
41. Lugo G., Cassady G., and Palmoisano P. Acute maternal arsenic intoxication with neonatal death. Am J Dis Child 117 (1969) 328-330
42. Mandal B.K., Ogra Y., and Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14 (2001) 371-378
43. McConnell B., and Vertino P. Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1. Cancer Res 60 22 (2000) 6243-6247
44. Mic F.A., Haselbeck R.J., Cuenca A.E., and Dester G. Novel retinoic acid generating activities in the neural tube and heart identified by conditional rescue of Raldh2 null mutant mice. Development 129 9 (2002) 2271-2282
45. Mirkes P.E., and Cornel L. A comparison of sodium arsenite- and hyperthermia-induced stress responses and abnormal development in cultured postimplantation rat embryos. Teratology 46 (1992) 251-259
46. Mitchell L.E. Epidemiology of neural tube defects. Am J Med Genet 135C (2005) 88-94
47. Morrissey R.E., and Mottet N.K. Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation. Teratology 28 (1983) 399-411
48. Nagymajtenyi L., Selypes A., and Berencsi G. Chromosomal aberrations and fetotoxic effects of atmospheric arsenic exposure in mice. J Appl Toxicol 5 (1985) 61-63
49. Nemec M.D., Holson J.F., Farr C.H., and Hood R.D. Developmental toxicity assessment of arsenic acid in mice and rabbits. Reprod Toxicol 12 (1998) 647-658
50. Nordstrom S., Beckman L., and Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. I. Variations in birth weight. Hereditas 88 (1978) 43-46
51. Nordstrom S., Beckman L., and Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. III. Frequencies of spontaneous abortion. Hereditas 88 (1978) 51-54
52. Nordstrom S., Beckman L., and Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. V. Spontaneous abortion among female employees and decreased birth weight in their offspring. Hereditas 90 (1979) 291-296
53. Nordstrom S., Beckman L., and Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. VI. Congenital malformations. Hereditas 90 (1979) 297-302
54. Oh H.S., Kwon H., Sun S., and Yang C. QM, a putative tumor suppressor, regulates proto-oncogene c-yes. J Biol Chem 277 39 (2002) 36489-36498
55. Petrick J.S., Jagadish B., Mash E.A., and Aposhian H.V. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol 14 (2001) 651-656
56. Piedrahita J.A., Oetama B., Bennett G.D., van Waes J., Kamen B.A., Richardson J., et al. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23 (1999) 228-232
57. Rasouli M.L., Nasir K., Blumenthal R.S., Park R., Aziz D.C., and Budoff M.J. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 181 1 (2005) 159-165
58. Ratnam M., Marquardt H., Duhring J.L., and Freisheim J.H. Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry 28 (1989) 8249-8254
59. Ross J.F., Chaudhuri P.K., and Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73 (1994) 2432-2443
60. Shalat S.L., Walker D.B., and Finnell R.H. Role of arsenic as a reproductive toxin with particular attention to neural tube defects. J Toxicol Environ Health 48 (1996) 253-272
61. Shi H., Shi X., and Liu K.J. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cel Biochem 255 (2004) 67-78
62. Shimizu S., Narita M., and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399 (1999) 483-487
63. Shriver S.P., Shriver M.D., Tirpak D.L., Bloch L.M., Hunt J.D., Ferrell R.E., et al. Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancers. Mutat Res 406 1 (1998) 9-23
64. Snell G.D., Fekete E., and Hummel K.P. The relation of mating, ovulation and the estrus smear in the house mouse to the time of day. Anat Rec 76 (1948) 30-54
65. Spiegelstein O., Lu X., Le X.C., Troen A., Selhub J., Melnyk S., et al. Effects of dietary folate intake and folate binding protein-2 (Folbp2) on urinary speciation of sodium arsenate in mice. Environ Pharmacol Toxicol 19 (2005) 1-7
66. Splaver A., Lamas G.A., and Hennekens C.H. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 148 1 (2004) 34-40
67. Susin S., Lorenzo H., Zamzami N., Marzo I., Snow B., Brothers G., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 6718 (1999) 441-446
68. Tabacova S., Baird D.D., Balabaeva L., Lolova D., and Petrov I. Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal-infant pairs from copper smelter area. Placenta 15 (1994) 873-881
69. Tabocova S., Hunter III E.S., and Gladen B.C. Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence. Toxicol Appl Pharmacol 138 (1996) 298-307
70. Tallquist M., and Soriano P. Cell autonomous requirement for Pdgfrα in populations of cranial and cardiac neural crest cells. Development 130 (2003) 507-518
71. USPHS Department of Health and Human Services, Agency for Toxic Substances and Disease Registry. Toxicological Profile for Arsenic; 2000. http://www.atsdr.cdc.gov/toxprofiles/tp2.pdf.
72. Willhite C.C., and Ferm V.H. Prenatal and developmental toxicology of arsenicals. Adv Exp Med Biol 177 (1984) 205-228
73. Wlodarczyk B.J., Bennett G.D., Calvin J.A., and Finnell R.H. Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. Reprod Toxicol 10 (1996) 447-454
74. Wlodarczyk B.J., Spiegelstein O., Gelineau-van Waes J., Vorce R.L., Lu X., Le C.X., et al. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. Toxicol Appl Pharmacol 177 (2001) 238-246
75. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan S, Kane DW, Reinhold WC, Lababidi S, Bussey KJ, Riss J, Barrett JC, Weinstein JN. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biology; 2003. http://www.genomebiology.com/2003/4/4/R28.
76. Zelikoff J.T., Bertin J.E., Burbacher T.M., Hunter E.S., Miller R.K., Silbergeld E.K., et al. Health risks associated with prenatal metal exposure. Fundam Appl Toxicol 25 (1995) 161-170
77. Zierler S., Theodore M., Cohen A., and Rothman K.J. Chemical quality of maternal drinking water and congenital heart disease. Int J Epidemiol 17 (1988) 589-594